We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Yourgene Health Plc | LSE:YGEN | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.515 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMYGEN
RNS Number : 7302M
Yourgene Health PLC
13 January 2023
Yourgene Health plc
("Yourgene" or the "Company")
Director/PDMR Shareholding
Manchester, UK - 13 January 2023: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it was notified on 12 January 2023 that Bill Chang, Chief Entrepreneur of the Company, purchased 5,000,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") on 12 January 2023 at an average price of 0.344p per share.
Following the purchase, Bill Chang is interested in 289,000,142(1) Ordinary Shares, representing approximately 9.10 per cent. of the Company's issued share capital.
(1) 280,000,142 Ordinary Shares are held by Changsform Innovations Pte Ltd, Bill Chang is a company director and beneficial owner of Changsform Innovations Pte Ltd.
Furthermore, the Company was notified on 13 January 2023 that Barry Hextall, Chief Financial Officer of the Company, purchased 2,500,000 Ordinary Shares on 13 January 2023 at an average price of 0.3678p per share.
Following the purchase, Barry Hextall is interested in 6,500,000 Ordinary Shares, representing approximately 0.20 per cent. of the Company's issued share capital.
This announcement contains inside information for the purposes of the UK Market Abuse Regulation.
The Directors of the Company take responsibility for this announcement.
Yourgene Health plc Tel: +44 (0)161 669 8122 Lyn Rees, Chief Executive Officer investors@yourgene-health.com Barry Hextall, Chief Financial Officer Joanne Cross, Director of Marketing Cairn Financial Advisers LLP (NOMAD) Tel: +44 (0)20 7213 0880 Liam Murray / Ludovico Lazzaretti Singer Capital Markets (Corporate Tel: +44 (0)20 7496 3000 Broker) Aubrey Powell / Tom Salvesen / George Tzimas Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com Relations) Paul McManus / Lianne Applegarth Mob: 07980 541 893 / Mob: 07584 391 303
About Yourgene Health
Yourgene Health is an international molecular diagnostics group which develops and commercialises integrated genomic technologies and services enabling genomic medicine in over 60 territories. The group works in partnership with global leaders in DNA technology to advance diagnostic science and support precision medicine.
Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and now infectious diseases. The Group's flagship products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and an extension into the precision medicine space with DPYD genotyping.
Yourgene has a range of innovative DNA sample preparation platforms, and launched Yourgene Genomic Services in 2020, which has enabled Yourgene to offer a global laboratory service network equipped to provide high quality genetic testing and bioinformatics solutions and serve as a full life-cycle partner for clinical, research and pharmaceutical organisations to support partners at the preclinical, clinical, and post-market stages to develop, manufacture, obtain regulatory approval and commercialise new products and services.
Yourgene Health is headquartered in Manchester, UK with offices in Taipei, Singapore, the US and Canada, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.
Details of the person discharging managerial responsibilities 1 / person closely associated a) Name Dr Bill Chang --------------------------------------- ---------------------------------- Reason for the notification 2 --------------------------------------------------------------------------- a) Position/status Chief Entrepreneur --------------------------------------- ---------------------------------- b) Initial notification Initial notification /Amendment --------------------------------------- ---------------------------------- Details of the issuer, emission allowance market participant, 3 auction platform, auctioneer or auction monitor --------------------------------------------------------------------------- a) Name Yourgene Health plc --------------------------------------- ---------------------------------- b) LEI 213800UUIT8BZE7QEH33 --------------------------------------- ---------------------------------- Details of the transaction(s): section to be repeated 4 for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --------------------------------------------------------------------------- a) Description of the Ordinary shares of 0.1p each financial instrument, type of instrument Identification code ISIN: GB00BN31ZD89 b) Nature of the transaction Purchase of ordinary shares --------------------------------------- ---------------------------------- c) Price(s) and volume(s) -------------- --------------- Price(s) Volume(s) -------------- --------------- 0.349p 1,000,000 -------------- --------------- 0.349p 1,000,000 -------------- --------------- 0.34p 1,000,000 -------------- --------------- 0.34p 900,000 -------------- --------------- 0.34p 100,000 -------------- --------------- 0.34p 900,000 -------------- --------------- 0.34p 100,000 -------------- --------------- d) Aggregated information - Aggregated volume 5,000,000 - Price 0.344p e) Date of the transaction 12 January 2023 --------------------------------------- ---------------------------------- f) Place of the transaction London --------------------------------------- ---------------------------------- 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Barry Hextall ----------------------------------------- --------------------------------- 2 Reason for the notification ---------------------------------------------------------------------------- a) Position/status Chief Financial Officer ----------------------------------------- --------------------------------- b) Initial notification Initial notification /Amendment ----------------------------------------- --------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---------------------------------------------------------------------------- a) Name Yourgene Health plc ----------------------------------------- --------------------------------- b) LEI 213800UUIT8BZE7QEH33 ----------------------------------------- --------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------------------- a) Description of the financial Ordinary shares of 0.1p each instrument, type of instrument Identification code ISIN: GB00BN31ZD89 b) Nature of the transaction Purchase of ordinary shares ----------------------------------------- --------------------------------- c) Price(s) and volume(s) -------------- -------------- Price(s) Volume(s) -------------- -------------- 0.3678p 2,500,000 -------------- -------------- d) Aggregated information N/A - Aggregated volume - Price e) Date of the transaction 13 January 2023 ----------------------------------------- --------------------------------- f) Place of the transaction UK
----------------------------------------- ---------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQXLFFXFLLBBE
(END) Dow Jones Newswires
January 13, 2023 11:27 ET (16:27 GMT)
1 Year Yourgene Health Chart |
1 Month Yourgene Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions